RAD50 and breast neoplasm: MRE11, a breast tumor suppressor and component of the MRE11-RAD50-NBS1 complex, plays a critical role in DNA end resection and initiation of ataxia-telangiectasia mutation-dependent (ATM-dependent) DNA damage signaling.